Skip to content
GradedGrading live · 2026
LongevityGraded
Menu

Graded review

System Labs Reviews: Every Price Is a First Month

System Labs publishes NAD+ at $89 and sermorelin at $109 — both struck through from $149 and $219, both first-month rates. What that means. July 2026.

Researched & graded by Tom Vance · Lead Reviews Analyst
Last graded
Evidence scorecard
A

Top of the scorecard

Grade A

CoreAge Rx

Doctor-reviewed longevity peptides and NAD+ with one published per-protocol price and built-in human support.

$93–$99/mo (12-mo plan)

Check availability
Pricing
Flat monthly, no membership
Pharmacy
503A compounding pharmacy
Labs
No labs required
Consult
Clinician review included
Support
1:1 nurse + dietitian

Advertising disclosure — we may earn a commission at no extra cost to you. Affiliate partners are listed first on the scorecard.

C

Also on the scorecard

Grade C

Try Ageless

Every advertised longevity price is an intro-code rate, and the site says outright the real figure arrives after review.

$176–$249/mo list

Visit Try Ageless

Every advertised longevity price is a limited-time intro-code rate: the real list prices are $249 (NAD+ injection) and $176 (sermorelin injection), not the $199 and $126 shown. Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.

The one-sentence version

System Labs is one of the few providers on this board whose entire catalogue is the thing the board ranks — NAD+ by injection and by nasal spray, sermorelin by injection and orally, plus glutathione — rather than a weight-loss shop with a peptide bolted on. It also does the rarer thing of printing a price on the page instead of hiding it behind an intake. The catch is what the printed price is: every published figure is a first month, shown struck through from a standing rate you start paying in month two. It grades B, 10 points out of 14, and the two points it drops are both about what the page does not say. The grade is computed from published terms alone and cannot see who pays us.

What it is, and who it's for

The operator is System Laboratories, Inc., and the site carries a LegitScript Certified badge. Its menu, verified on 31 July 2026, is: NAD+ injection, NAD+ nasal spray, sermorelin injection, oral compounded sermorelin, glutathione injection, MIC+B12, GHK-CU cream, and compounded GLP-1/GIP.

Read that list next to the rest of this board and the shape is unusual. Most of the providers here are GLP-1 operators that added an anti-aging category; four of System Labs' eight items are the NAD+ and sermorelin routes this ranking is built on, and the GLP-1 line is the appendage rather than the core. If you came looking for a longevity menu rather than a weight-loss menu with one, this is a genuine fit — which is the whole of the four points it takes on the longevity-line factor. On whether that menu is worth buying at all, read what the evidence actually shows first.

What it actually costs

All figures below were read on System Labs' product landers on 31 July 2026, and they are quoted with the qualifier attached because the qualifier is the story.

NAD+"$149" struck through to "$89 /first mo."

Sermorelin"Monthly Supply (5mg)", "$219" struck through to "$109 /first mo." The copy beside it reads "Support deeper sleep, faster recovery, and leaner muscle. All from your own growth hormone."

Compounded GLP-1/GIP"COMPOUNDED GLP-1/GIP", "Monthly Supply (All doses)", "$179" struck through to "$99 /first mo."

Three products, three prices, and the same structure on all three: the number in large type is a first month, and the number it is struck through from is the rate that follows. $89 becomes $149. $109 becomes $219. $99 becomes $179. Nothing here is hidden — System Labs prints both figures, which is more than several providers on this board manage at all — but a reader who takes the large number as the price has budgeted for the wrong one from the first refill onward.

It is worth being precise about why that still earns the four price-transparency points rather than zero. Our rubric asks for a single all-in figure, visible before you commit, that a buyer with no commitment actually pays. System Labs publishes one: $149 for NAD+, on the same line as the promotional rate, with no prepay term attached to it. Compare that with the providers here whose advertised figure turns out to be a twelve-month prepay, or is quoted only inside the portal — see the Gala Health review and the Shed review for what an unpublished monthly price looks like. A teaser beside a standing rate is a marketing tactic. A price that does not exist until checkout is a different failure, and a worse one.

What every lander includes. All three carry the same four lines: "20% off Rythm blood test", "Injection supplies included", "2-day temp-controlled shipping", and "Ongoing support from a real care team." The last of those is what earns the human-support points — support stated as inside the price, not sold as an upgrade.

The first month, and the month after it

ProductFirst monthStanding rate
NAD+$89 /first mo$149
Sermorelin (5mg)$109 /first mo$219
Compounded GLP-1/GIP$99 /first mo$179
Consult included?Not statedNot stated
PharmacyNot namedNo 503A claim
Verified 31 July 2026 on System Labs' product landers. Both numbers are printed — only one of them is the price you keep paying.

The two points it drops, and why

Clinical oversight: zero. Nothing on the lander states whether the clinician visit is included in the published price. That is the whole finding, and we have deliberately not resolved it in either direction. These are prescription products, so a prescriber is involved somewhere; what is not published is whether the $89 or the $149 covers that consultation or whether it is billed separately. Our rubric scores an unstated consult exactly as it scores one billed on top, because a buyer cannot budget for a fee nobody has quoted. If System Labs states the position on the lander, this becomes two points immediately.

Pharmacy disclosure: zero. No dispensing or compounding pharmacy is named, and no compounding standard — 503A or 503B — is claimed. The LegitScript Certified badge is a real signal and worth having, but it certifies the seller's compliance, not the pharmacy that fills the vial; it is not a facility name and not a classification. We applied that identically to Strut Health, whose ACHC seals earned nothing on this factor either. FDA's position on what an unnamed compounder leaves open is blunt: compounded drugs are not FDA-approved, and the agency does not verify their safety, effectiveness or quality before they are marketed1.

One structural oddity worth knowing. The prices above live on System Labs' product landers. Its own `/nad` path is an intake questionnaire rather than a product page — so a reader who arrives at the site and browses does not necessarily reach the page with the price on it. That is not a hidden price; it is a published price on a page the site's own navigation does not lead with.

The evidence behind what it sells

This is where a good menu meets a thin trial record, and the sermorelin copy is the sharper example. "Support deeper sleep, faster recovery, and leaner muscle. All from your own growth hormone" describes a mechanism accurately and then attaches outcomes to it that the trials did not produce. The study that tested this exact protocol gave GHRH 1-29 nightly for six weeks to eleven healthy men aged 64–76: nocturnal growth hormone rose significantly, but IGF-1 did not change and DEXA-measured muscle and fat did not change2. The landmark review of growth hormone in healthy older adults found small body-composition shifts, no proven functional benefit, and significantly more adverse events3. See peptides for longevity.

NAD+ is no better supported, and the specific gap matters here because System Labs sells it as an injection and a nasal spray. The 2026 PRISMA-guided systematic review of NAD+ for anti-aging and wellness screened 113 studies including 33 human intervention trials, found effects on functional, metabolic and vascular outcomes "heterogeneous and often null or endpoint-specific", and reported that no eligible outcomes trial has evaluated intravenous or intramuscular NAD+ for these indications at all4. A 2025 meta-analysis in adults averaging over 60 found NAD+ precursors did not improve muscle index, grip strength, gait speed or chair-stand time5. See NAD+ for longevity and do NAD+ peptides work.

None of that is a mark against System Labs specifically — it is the state of the category, and this board grades providers rather than the medicine. But a buyer who is paying $149 a month from the second month onward should know the outcomes being described have not been demonstrated.

Before you start

Four things to settle before you pay System Labs

  • Budget at $149 for NAD+ and $219 for sermorelin. The $89 and $109 are labelled first-month rates and both landers say so.
  • Ask whether the clinician consultation is inside that figure. No lander states it either way, and an unstated consult is the reason this row is not an A.
  • Ask which pharmacy fills the vial and whether it is a 503A facility. Neither is published, and the LegitScript badge certifies the seller rather than the compounder.
  • The prices live on the product landers. The site's own /nad path is an intake questionnaire, so browsing is not the same as finding the price.

Where it's weak, and who should skip it

Skip it if the first month is doing the work in your budget: run the arithmetic at $149 for NAD+ or $219 for sermorelin, because those are the numbers you live with. Skip it if you need to know the consultation cost before you start, since the landers do not state it. And skip it if you want to know which pharmacy fills your vial — Telos Rx names both of its dispensing pharmacies with street addresses, which no other provider here does.

Buy it if the menu is what you actually want. Four longevity routes under one intake, injection supplies and temperature-controlled shipping inside the price, and a published standing rate to plan against is a better starting position than most of this board offers.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). System Labs takes the full four for its longevity line — NAD+ by two routes plus sermorelin by two more is as complete a longevity shelf as this board has — four for price transparency, because a standing monthly rate is published beside the promotional one with no prepay term attached, and two for human support, stated on every lander. It takes zero for clinical oversight, because whether the visit is inside the price is never stated, and zero for pharmacy, because no dispensing facility is named and no compounding standard is claimed. Ten out of fourteen: a B.

Both missing points are sentences, not systems. Publish whether the consult is included, and name the pharmacy or state its compounding standard, and System Labs would be at fourteen without changing a single term of the offer. Until then it sits mid-table with a strong menu and a page that will not finish the sentence. The full field is at our provider rankings, and the scoring is set out in how we grade.

Frequently asked questions

How much does System Labs cost?

Verified 31 July 2026 on System Labs' product landers. NAD+ publishes '$149' struck through to '$89 /first mo'. Sermorelin publishes 'Monthly Supply (5mg)' at '$219' struck through to '$109 /first mo'. Compounded GLP-1/GIP publishes 'Monthly Supply (All doses)' at '$179' struck through to '$99 /first mo'. Every figure follows the same structure: the large number is a first month and the struck-through number beside it is the standing rate from the second month onward, so $89 becomes $149, $109 becomes $219 and $99 becomes $179. Budget at the standing rate. Every lander also states four inclusions — '20% off Rythm blood test', 'Injection supplies included', '2-day temp-controlled shipping' and 'Ongoing support from a real care team' — but none of them states whether the clinician consultation is included in the published price, so the all-in cost of starting cannot be worked out from the page.

Does System Labs have transparent pricing?

It publishes a price, which is not the same thing, and the distinction is the reason this review exists. Every figure System Labs prints is a first-month teaser shown against a struck-through standing rate: $89 against $149 for NAD+, $109 against $219 for sermorelin, $99 against $179 for compounded GLP-1/GIP. That is genuinely better than the providers on this board whose advertised figure turns out to be a twelve-month prepay, or who quote no price at all until you are inside the portal — the standing rate is printed, on the same line, with no prepay term attached to it, which is why System Labs takes the full four price-transparency points. But it is not a provider with one honest number on the page, and describing it that way would misread a discount as a rate. Two things are also not published anywhere on the landers: whether the consultation is included, and which pharmacy dispenses.

What does System Labs sell?

Verified 31 July 2026: NAD+ injection, NAD+ nasal spray, sermorelin injection, oral compounded sermorelin, glutathione injection, MIC+B12, GHK-CU cream, and compounded GLP-1/GIP. The operator is System Laboratories, Inc., and the site carries a LegitScript Certified badge. That menu is the reason it takes full marks on our longevity-line factor: four of the eight items are the NAD+ and sermorelin routes this board is built to rank, so the weight-loss line is the appendage rather than the core — the opposite shape to most providers here, which are GLP-1 operators that added an anti-aging category later. One structural note: the published prices sit on System Labs' product landers, while its own /nad path is an intake questionnaire rather than a product page, so a reader browsing the site does not necessarily arrive at the page with the price on it.

Why does System Labs grade B rather than A?

Ten points out of fourteen, and the four it drops are both unstated facts rather than bad terms. Clinical oversight is worth two and System Labs scores zero: nothing on the lander says whether the clinician visit is included in the published price. These are prescription products so a prescriber is involved, but our rubric scores an unstated consult exactly as it scores one billed on top, because a buyer cannot budget for a fee nobody has quoted. Pharmacy disclosure is worth two and it also scores zero: no dispensing or compounding pharmacy is named and no 503A or 503B standard is claimed. The LegitScript Certified badge is a real signal, but it certifies the seller's compliance rather than the pharmacy that fills the vial, which is the identical call we made on Strut Health's ACHC seals. It takes the full four for its longevity line, four for publishing a standing price, and two for stating that support is inside it. Both missing points are sentences the company could add to the page tomorrow.

References

  1. U.S. Food and Drug Administration (2025). Compounding and the FDA: Questions and Answers ('Compounded drugs are not FDA-approved'; 503A pharmacies are not subject to CGMP requirements). FDA — Human Drug Compounding. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  2. Vittone J, Blackman MR, Busby-Whitehead J, et al. (1997). Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. https://pubmed.ncbi.nlm.nih.gov/9005976/
  3. Liu H, Bravata DM, Olkin I, et al. (2007). Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/17227934/
  4. Gallagher C, Emmanuel OO (2026). NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews. https://pubmed.ncbi.nlm.nih.gov/41655607/
  5. Prokopidis K, Moriarty F, Bahat G, et al. (2025). The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle. https://pubmed.ncbi.nlm.nih.gov/40275690/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.